FDA Approves ACYCLOVIR — Chartwell Governmental & Specialty RX, LLC.
Chartwell Governmental & Specialty RX, LLC. announced the approval of its generic acyclovir ANDA (app# ANDA212718), which significantly broadens market accessibility for this antiviral drug amid sustained demand. This regulatory milestone is anticipated to intensify competitive pressure and drive immediate cost savings for payers following the potential expiration of multiple brand exclusivity periods.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed